Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 申联生物医药（上海）股份有限公司成立于2001年，位于上海市闵行区紫竹科学园区江川东路48号，注册资金35970万元，是国内第一家合成肽疫苗生产企业，是一家坚持自主创新的国家高新技术企业。 公司的研发队伍由行业经验丰富、跨领域、多学科的技术专家和海归博士组成，研发实力卓著。目前已获得国家专利60项，涉及产品研发、生产工艺，设备改进，产品设计等多层面，致力打造创新型疫苗生产线。 在国内猪口蹄疫合成肽疫苗市场，申联生物的销量一直领先，市场遍布全国30个省市，产品和服务获得用户的广泛认可和一致好评。 公司秉承“矢志品质，践于匠行”品牌理念，致力于研发生产具有行业领先水平的疫苗，全心全意服务于中国畜牧业，将继续赢得用户、员工、公众的尊重和信任，成为值得信赖的行业领先企业。
Main Business 专业从事兽用生物制品研发、生产、销售的高新技术企业。
Legal Representative 聂东升
Top Executives
董事长：聂东升
董事：童光志,吴楚宇,聂文豪,林淑菁,杨从州
独立董事：李建军,潘春雨,吴守常
Top 5 Shareholder
Shareholder name Nature Holding Date
杨玉芳流通A股21.93%31/03/2024
UNITED BIOMEDICAL,INC.流通A股10.52%31/03/2024
杨从州流通A股7.31%31/03/2024
上海申太联投资合伙企业（有限合伙）流通A股5.04%31/03/2024
王惠尚流通A股4.60%31/03/2024
Company Secretary 於海霞
Solicitors 国浩律师（上海）事务所
Auditors 大华会计师事务所（特殊普通合伙）
Tel No 021-61255101
Fax No 021-61267296
Website www.slbio.com.cn
Email slsw@slbio.com.cn
Company Address
Register: 上海市闵行区江川东路48号
Office: 上海市闵行区江川东路48号
Listing Date 28/10/2019
Shares Capital
Shares Capital: 410,644,000
Total A Share: 410,644,000
Listed A Share: 410,644,000
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.080
DPS(RMB)* ¥ 0.035
NBV Per Share(RMB)* ¥ 3.625
Market Capitalization(RMB) 2.259B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.